The grant from the Bill & Melinda Gates foundation, to offer kits that allowed you to detect the coronavirus that is not enough, the organization announced on Tuesday (10), which is the Covid-19 Therapeutics Acceleratorprogram that will invest up to US$ 125 million in research to identify, evaluate, and treat infection by the virus.
- Immutouch this is a bracelet that vibrates to you, don’t touch your face
- Coronavirus: good in parts, affects over 70% of the consumer electronics industry in Brazil
The initiative is the result of a partnership between the Bill & Melinda Gates Foundation, the NGO, Wellcome trust, and the Mastercard from This Fund. The first two will be a maximum of US$ 50 million for the project. Already, Mastercard will provide up to$ 25 million. The research work will be carried out in partnership with the World Health Organization (WHO), and governmental agencies of various countries.
The main objective of the Covid-19 And Therapeutics the application is to identify and develop drugs for the treatment of the Covid-19. A grant from the Bill & Melinda Gates foundation, explains that, up to the present time, there is no antiviral or immunotherapy approved for use to combat the coronavirus, so that the focus is on that aspect.
“Virus [that causes] the Covid-19 to spread rapidly, but the development of new vaccines and treatments to get rid of them is a lot more sluggish,” adds Mark Suzman, president and ceo of the Bill & Melinda Gates Foundation. Therefore, the idea is to do the research on the issue to move forward more quickly.
To this end, the activities of the Covid-19 Therapeutics Accelerator, which will be carried out not only in a partnership with the world health organization and governments, as well as with the private sector, and other non-profit organizations.
This openness comes from the experience of a grant from the Bill & Melinda Gates foundation in fighting the outbreak of Ebola in 2014: at that time, the organization realized that an approach using multiple agents working together has a better chance of success.
The work will not be lacking. The program is based on three different strategies to identify potential therapies, and to work with industry partners to develop and co-ordinate the delivery of the treatments on the market, together with the health authorities.
The program shall consider all of the steps that are necessary to this end, the research of therapies and the development of methods of production. Our goal is to provide medications at an affordable cost, especially in low-resource settings.
Tecnocast 136 — The impact of coronaviruses on the technology
It seems that the coronavirus would be in the passenger seat. But it has been spreading dramatically and it has already disrupted the plans of the companies all over the world, including in the technology sector.
In this program, we are talking about the impact so far by the outbreak, and the possible consequences if the situation is not controlled in the next few weeks. It gives the play, and come with us!